Q3-osavuosiraportti
13 päivää sitten‧41 min
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
164 823
Myynti
Määrä
61 776
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 487 | - | - | ||
| 8 000 | - | - | ||
| 8 410 | - | - | ||
| 416 | - | - | ||
| 6 604 | - | - |
Ylin
1,965VWAP
Alin
1,761VaihtoMäärä
2,1 1 150 022
VWAP
Ylin
1,965Alin
1,761VaihtoMäärä
2,1 1 150 022
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 150 022 | 1 150 022 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 150 022 | 1 150 022 | 0 | 0 |
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Ylimääräinen yhtiökokous | 25.11. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 23.10. | |
| 2025 Q2-osavuosiraportti | 10.7. | |
| 2024 Yhtiökokous | 7.5. | |
| 2025 Q1-osavuosiraportti | 24.4. | |
| Splittaus | 7.4. |
Datan lähde: Millistream, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·10 t sittenit's damn incredible only 8 months ago they made a huge dilutive share issue and subsequent reverse split because otherwise the stock would have gone into negative ???? what a shitty management that burns money like no other apart from Xbrane which also struggles with bad management what they have in common is that they get excessively high salaries -they can't figure out sales- they can't enter into partnership agreements that are favorable for the shareholders - they can't figure out how to control costs. = incompetent managements unbelievable that this can happen
·2 päivää sittenWell then, extraordinary general meeting on 24-11, what's on it ⸻ ✅ What we know • The company has issued a notice for an extraordinary general meeting. • In the notice, the agenda includes, among other things: • Amendment of the Articles of Association (Articles of Association) – including amendment of the share capital framework and the number of shares. • Capital reduction to cover losses. • Approval of the board's decision on a new directed rights issue (rights issue of units) where each unit consists of ordinary shares and warrants. • Authorization of the board to issue ordinary shares and warrants with deviation from the shareholders' pre-emptive rights. • A provision that the board may issue new shares, convertibles or warrants up to 20 % of the outstanding shares upon first utilization of the authorization. Based on the agenda and previous communication, the answer is: yes, the possibility for further issues is clearly present. Specific points: • Item 8: approval of the board's decision on a directed issue (“rights issue of units”) shows that the company wishes to issue new shares + warrants. • Item 11: authorization to the board to issue shares/convertibles/warrants with deviation from pre-emptive rights indicates the possibility of a share capital increase. • The amendment of the Articles of Association, including the figure for maximum share capital and maximum number of shares (§5) shows that frameworks for significant expansion are being prepared. Example: alternative B proposes that the number of shares “not less than 500,000,000 and not more than 2,000,000,000”. So yes — it clearly looks like the company is preparing an issue/expansion. Whether it will be carried out and with exactly how many shares, when and at what price, that has not yet been announced in detail.
·1 päivä sitten · Muokattu@ByggeBob... "So yes — it clearly looks like the company is preparing an issue/capital increase". Looks like? - Haven't you read the press release from 22/10? Here they just announced a rights issue. The approvals for this must then be in place at the general meeting, and the subscription price will be 65% of vwap in the period 18-24 Nov. https://www.nordnet.dk/markedet/nyheder/0c4c89f3-74de-45bd-9faf-69566380e266 Edited: I wrote "directed issue", which was a mistake. It has now been corrected to "rights issue"
·27.10.It's hard to be impressed with the management - and it's hard not to be impressed with the clinical data with Mitazalimab. There should be a market for this product, but it's hard for us poor small investors to figure out what the hell is going on. So far I've lost several hundred thousand kroner, which has probably primarily ended up directly in Søren Bregenholt's pockets.- ·24.10.at the rate the fall is going, the price will probably end up at 0.000. Damn, it hurts to be in this case in 4 portfolios, and the same with Xbrane in the same portfolios. A just as poorly managed company. There are many bad similarities between the 2 companies, and the only salvation is that the management in both companies should be replaced with more competent and market-adapted people.
·24.10.If you think the price ends at 0.00, then there is only one way LP90
24.10.24.10.He don't think it really, hope not , the point to be investor is to make money, not to hope to get your investment back , he is right in everything he writing, we not here for charity support office workers, but looks like times changed , on the top we have useless management workers , we have bots , algorithms and all sorts of economic manipulations , internet dictating the rules, soon we back hundred years ago where people saying buy land to be rich , scum company like this milking shareholders is nonsense, Hello - 99.99% , this is scum not business project, many companies fail in Phase 3 too , and here looks like no big Pharma want to take it
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Q3-osavuosiraportti
13 päivää sitten‧41 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·10 t sittenit's damn incredible only 8 months ago they made a huge dilutive share issue and subsequent reverse split because otherwise the stock would have gone into negative ???? what a shitty management that burns money like no other apart from Xbrane which also struggles with bad management what they have in common is that they get excessively high salaries -they can't figure out sales- they can't enter into partnership agreements that are favorable for the shareholders - they can't figure out how to control costs. = incompetent managements unbelievable that this can happen
- ·2 päivää sittenWell then, extraordinary general meeting on 24-11, what's on it ⸻ ✅ What we know • The company has issued a notice for an extraordinary general meeting. • In the notice, the agenda includes, among other things: • Amendment of the Articles of Association (Articles of Association) – including amendment of the share capital framework and the number of shares. • Capital reduction to cover losses. • Approval of the board's decision on a new directed rights issue (rights issue of units) where each unit consists of ordinary shares and warrants. • Authorization of the board to issue ordinary shares and warrants with deviation from the shareholders' pre-emptive rights. • A provision that the board may issue new shares, convertibles or warrants up to 20 % of the outstanding shares upon first utilization of the authorization. Based on the agenda and previous communication, the answer is: yes, the possibility for further issues is clearly present. Specific points: • Item 8: approval of the board's decision on a directed issue (“rights issue of units”) shows that the company wishes to issue new shares + warrants. • Item 11: authorization to the board to issue shares/convertibles/warrants with deviation from pre-emptive rights indicates the possibility of a share capital increase. • The amendment of the Articles of Association, including the figure for maximum share capital and maximum number of shares (§5) shows that frameworks for significant expansion are being prepared. Example: alternative B proposes that the number of shares “not less than 500,000,000 and not more than 2,000,000,000”. So yes — it clearly looks like the company is preparing an issue/expansion. Whether it will be carried out and with exactly how many shares, when and at what price, that has not yet been announced in detail.·1 päivä sitten · Muokattu@ByggeBob... "So yes — it clearly looks like the company is preparing an issue/capital increase". Looks like? - Haven't you read the press release from 22/10? Here they just announced a rights issue. The approvals for this must then be in place at the general meeting, and the subscription price will be 65% of vwap in the period 18-24 Nov. https://www.nordnet.dk/markedet/nyheder/0c4c89f3-74de-45bd-9faf-69566380e266 Edited: I wrote "directed issue", which was a mistake. It has now been corrected to "rights issue"
- ·27.10.It's hard to be impressed with the management - and it's hard not to be impressed with the clinical data with Mitazalimab. There should be a market for this product, but it's hard for us poor small investors to figure out what the hell is going on. So far I've lost several hundred thousand kroner, which has probably primarily ended up directly in Søren Bregenholt's pockets.
- ·24.10.at the rate the fall is going, the price will probably end up at 0.000. Damn, it hurts to be in this case in 4 portfolios, and the same with Xbrane in the same portfolios. A just as poorly managed company. There are many bad similarities between the 2 companies, and the only salvation is that the management in both companies should be replaced with more competent and market-adapted people.·24.10.If you think the price ends at 0.00, then there is only one way LP9024.10.24.10.He don't think it really, hope not , the point to be investor is to make money, not to hope to get your investment back , he is right in everything he writing, we not here for charity support office workers, but looks like times changed , on the top we have useless management workers , we have bots , algorithms and all sorts of economic manipulations , internet dictating the rules, soon we back hundred years ago where people saying buy land to be rich , scum company like this milking shareholders is nonsense, Hello - 99.99% , this is scum not business project, many companies fail in Phase 3 too , and here looks like no big Pharma want to take it
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
164 823
Myynti
Määrä
61 776
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 487 | - | - | ||
| 8 000 | - | - | ||
| 8 410 | - | - | ||
| 416 | - | - | ||
| 6 604 | - | - |
Ylin
1,965VWAP
Alin
1,761VaihtoMäärä
2,1 1 150 022
VWAP
Ylin
1,965Alin
1,761VaihtoMäärä
2,1 1 150 022
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 150 022 | 1 150 022 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 150 022 | 1 150 022 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Ylimääräinen yhtiökokous | 25.11. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 23.10. | |
| 2025 Q2-osavuosiraportti | 10.7. | |
| 2024 Yhtiökokous | 7.5. | |
| 2025 Q1-osavuosiraportti | 24.4. | |
| Splittaus | 7.4. |
Datan lähde: Millistream, Quartr
Q3-osavuosiraportti
13 päivää sitten‧41 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Ylimääräinen yhtiökokous | 25.11. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 23.10. | |
| 2025 Q2-osavuosiraportti | 10.7. | |
| 2024 Yhtiökokous | 7.5. | |
| 2025 Q1-osavuosiraportti | 24.4. | |
| Splittaus | 7.4. |
Datan lähde: Millistream, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·10 t sittenit's damn incredible only 8 months ago they made a huge dilutive share issue and subsequent reverse split because otherwise the stock would have gone into negative ???? what a shitty management that burns money like no other apart from Xbrane which also struggles with bad management what they have in common is that they get excessively high salaries -they can't figure out sales- they can't enter into partnership agreements that are favorable for the shareholders - they can't figure out how to control costs. = incompetent managements unbelievable that this can happen
- ·2 päivää sittenWell then, extraordinary general meeting on 24-11, what's on it ⸻ ✅ What we know • The company has issued a notice for an extraordinary general meeting. • In the notice, the agenda includes, among other things: • Amendment of the Articles of Association (Articles of Association) – including amendment of the share capital framework and the number of shares. • Capital reduction to cover losses. • Approval of the board's decision on a new directed rights issue (rights issue of units) where each unit consists of ordinary shares and warrants. • Authorization of the board to issue ordinary shares and warrants with deviation from the shareholders' pre-emptive rights. • A provision that the board may issue new shares, convertibles or warrants up to 20 % of the outstanding shares upon first utilization of the authorization. Based on the agenda and previous communication, the answer is: yes, the possibility for further issues is clearly present. Specific points: • Item 8: approval of the board's decision on a directed issue (“rights issue of units”) shows that the company wishes to issue new shares + warrants. • Item 11: authorization to the board to issue shares/convertibles/warrants with deviation from pre-emptive rights indicates the possibility of a share capital increase. • The amendment of the Articles of Association, including the figure for maximum share capital and maximum number of shares (§5) shows that frameworks for significant expansion are being prepared. Example: alternative B proposes that the number of shares “not less than 500,000,000 and not more than 2,000,000,000”. So yes — it clearly looks like the company is preparing an issue/expansion. Whether it will be carried out and with exactly how many shares, when and at what price, that has not yet been announced in detail.·1 päivä sitten · Muokattu@ByggeBob... "So yes — it clearly looks like the company is preparing an issue/capital increase". Looks like? - Haven't you read the press release from 22/10? Here they just announced a rights issue. The approvals for this must then be in place at the general meeting, and the subscription price will be 65% of vwap in the period 18-24 Nov. https://www.nordnet.dk/markedet/nyheder/0c4c89f3-74de-45bd-9faf-69566380e266 Edited: I wrote "directed issue", which was a mistake. It has now been corrected to "rights issue"
- ·27.10.It's hard to be impressed with the management - and it's hard not to be impressed with the clinical data with Mitazalimab. There should be a market for this product, but it's hard for us poor small investors to figure out what the hell is going on. So far I've lost several hundred thousand kroner, which has probably primarily ended up directly in Søren Bregenholt's pockets.
- ·24.10.at the rate the fall is going, the price will probably end up at 0.000. Damn, it hurts to be in this case in 4 portfolios, and the same with Xbrane in the same portfolios. A just as poorly managed company. There are many bad similarities between the 2 companies, and the only salvation is that the management in both companies should be replaced with more competent and market-adapted people.·24.10.If you think the price ends at 0.00, then there is only one way LP9024.10.24.10.He don't think it really, hope not , the point to be investor is to make money, not to hope to get your investment back , he is right in everything he writing, we not here for charity support office workers, but looks like times changed , on the top we have useless management workers , we have bots , algorithms and all sorts of economic manipulations , internet dictating the rules, soon we back hundred years ago where people saying buy land to be rich , scum company like this milking shareholders is nonsense, Hello - 99.99% , this is scum not business project, many companies fail in Phase 3 too , and here looks like no big Pharma want to take it
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
164 823
Myynti
Määrä
61 776
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 487 | - | - | ||
| 8 000 | - | - | ||
| 8 410 | - | - | ||
| 416 | - | - | ||
| 6 604 | - | - |
Ylin
1,965VWAP
Alin
1,761VaihtoMäärä
2,1 1 150 022
VWAP
Ylin
1,965Alin
1,761VaihtoMäärä
2,1 1 150 022
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 150 022 | 1 150 022 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 150 022 | 1 150 022 | 0 | 0 |